Figure 3

Changes in cir-miRNA-126 (cir-miRNA-126) levels from baseline to first clinical evaluation (after three weeks) in (A) non-responding patients ( N =32) and (B) responding patients ( N =31). Green and red lines are used to differentiate between the increasing and decreasing miRNA-126 levels, respectively.